| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.36 | 0.08 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |